Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype

BACKGROUND: The shortcomings of clonazepam therapy include tolerance, withdrawal symptoms, and adverse effects such as drowsiness, dizziness, and confusion leading to increased risk of falls. Inter-individual variability in the incidence of adverse events in patients partly originates from the diffe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Neuropsychopharmacol
Main Authors: Tóth, Katalin, Csukly, Gábor, Sirok, Dávid, Belic, Ales, Kiss, Ádám, Háfra, Edit, Déri, Máté, Menus, Ádám, Bitter, István, Monostory, Katalin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Regular Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203763/
https://ncbi.nlm.nih.gov/pubmed/27639091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyw083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados